Patent ID: 7579010
Filing Date: 2009-08-25
Classification: A61K,A61P,Y02A

Abstract:
1. A pharmaceutical composition, consisting essentially of (a) a botulinum toxin; (b) a caprylate; (c) a recombinant human serum albumin (rHSA), (d) a polysorbate 80 (P80), and; (e) sodium chloride, wherein for each 100 units of the botulinum toxin there is present in the pharmaceutical composition, about 7 milligrams or about 13 micrograms of the caprylate, about 500 micrograms of the rHSA, about 0.04 micrograms of the P80 and about 900 micrograms of the sodium chloride, wherein said pharmaceutical composition weighs about 1.4 milligrams and has a % recovery after lyophilization and reconstitution with saline of greater than 90%.